Clinical Trial Update: Methotrexate Polyglutamates as a Marker of Clinical Response and Toxicity in the Treatment of Psoriasis

View source ↗

Summary

A clinical trial investigates methotrexate polyglutamates as biomarkers for response and toxicity in psoriasis treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: King's College London | Conditions: Psoriasis Chronic, Injury of Liver | Status: UNKNOWN